Clinical Trial: Collaborative Ocular Melanoma Study (COMS)

Study Status: Active, not recruiting
Recruit Status: Unknown status
Study Type: Interventional




Official Title:

Brief Summary:

To evaluate therapeutic interventions for patients who have choroidal melanoma, the most common primary eye cancer affecting adults, and to assess the potential life-preserving as well as sight-preserving role of radiation therapy.

To determine which of two standard treatments, removal of the eye or brachytherapy, is more likely to prolong survival of eligible patients with medium-sized choroidal melanoma.

To determine whether preoperative radiation prolongs life for patients whose eyes with large choroidal melanoma are enucleated.